A powerful and inexpensive technique for rewriting snippets of DNA — known as CRISPR-Cas9 — has two research institutions locked in a bitter patent battle. On one side is UC Berkeley, where faculty first reported using the gene-editing technology in 2012, on the other, Broad Institute of MIT and Harvard, where faculty won a special expedited patent for the technique in 2014.
Office of Strategic Communication